The company was founded in June 1979 and is headquartered in Eden Prairie, MN. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that the United States Food and Drug.
The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. It operates through the Medical Device and In Vitro Diagnostics segments. Surmodics ( NASDAQ: SRDX) announces the successful first uses with patients for two devices within its Sublime Radial Access Platform: the Sublime Radial Access Guide Sheath and Sublime Radial. (NASDAQ : SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced today that its Pounce Thrombectomy System achieved 100 percent technical success in 20 First-in-Human (FIH) procedures. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. Available in five lengths from 65 to 200 cm and compatible with 0.014, 0.018, and 0.035 guidewires, the Sublime microcatheters feature Surmodics’ best-in-class Pristyne hydrophilic coating for. See which 3 stocks are most likely to make moves following their insider activities. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions.
0 kommentar(er)
